SciVision Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	845.81	706.02	511.1	587.02	658.92
Short-Term Investments	79.9	99.9	233.9	30.71	36.92
Trading Asset Securities	128.65	-	-	-	-
Cash & Short-Term Investments	1,054	805.92	745	617.73	695.84
Cash Growth	30.83%	8.18%	20.60%	-11.23%	68.36%
Accounts Receivable	242.14	172.94	95.18	90.34	78.37
Other Receivables	1.56	1.09	1.02	1.16	0.2
Receivables	243.7	174.02	96.21	91.49	78.56
Inventory	82.15	72.23	87.25	95.87	82.9
Prepaid Expenses	46.39	47.94	15.48	18.65	21.7
Other Current Assets	0.59	66.3	59.97	57.29	46.24
Total Current Assets	1,427	1,166	1,004	881.03	925.24
Property, Plant & Equipment	1,228	1,176	1,135	1,184	1,246
Other Intangible Assets	1.4	1.68	2.15	2.67	3.38
Long-Term Deferred Tax Assets	7.14	5.02	15.5	25.04	31.33
Other Long-Term Assets	6.2	5.01	3.22	5.23	56.48
Total Assets	2,670	2,354	2,160	2,098	2,262
Accounts Payable	16.4	13.27	6.75	14.02	5.46
Accrued Expenses	-	135.76	102.56	78.4	-
Short-Term Debt	0.51	-	-	-	-
Current Portion of Long-Term Debt	-	134.79	-	-	303.37
Current Portion of Leases	10.18	4.73	1.22	1.2	1.24
Current Income Taxes Payable	2.39	12.65	5.77	13.97	-
Current Unearned Revenue	1.55	2.68	7.02	0.7	1.71
Other Current Liabilities	143.62	33.19	21.69	19.79	113.86
Total Current Liabilities	174.65	337.07	144.99	128.08	425.64
Long-Term Debt	373.59	-	323.84	386.69	300
Long-Term Leases	100.86	84.72	22.85	24.1	28.48
Pension & Post-Retirement Benefits	-	8.14	18.92	25.47	35.16
Long-Term Deferred Tax Liabilities	0.49	4.35	0.03	0.05	-
Other Long-Term Liabilities	39.76	23.15	23.03	22.91	22.78
Total Liabilities	689.35	457.43	533.67	587.31	812.06
Common Stock	748.28	717.92	677.1	661.9	661.9
Additional Paid-In Capital	960.31	844.08	700.34	648.26	638.12
Retained Earnings	272.47	335.25	249.73	201.61	150.72
Comprehensive Income & Other	-0.82	-0.2	-0.66	-0.84	-0.86
Shareholders' Equity	1,980	1,897	1,627	1,511	1,450
Total Liabilities & Equity	2,670	2,354	2,160	2,098	2,262
Total Debt	485.13	224.24	347.91	411.99	633.09
Net Cash (Debt)	569.22	581.69	397.09	205.74	62.75
Net Cash Growth	-2.14%	46.49%	93.01%	227.89%	-31.96%
Net Cash Per Share	7.64	7.81	5.19	2.76	0.88
Filing Date Shares Outstanding	73.83	71.79	67.71	66.19	66.19
Total Common Shares Outstanding	73.83	71.79	67.71	66.19	66.19
Working Capital	1,253	829.35	858.92	752.95	499.6
Book Value Per Share	26.82	26.42	24.02	22.83	21.90
Tangible Book Value	1,979	1,895	1,624	1,508	1,446
Tangible Book Value Per Share	26.80	26.40	23.99	22.79	21.85
Land	-	4.73	4.73	4.73	9.5
Buildings	-	687.72	686.59	686.32	688.54
Machinery	-	926.47	909.63	896.45	891.02
Construction In Progress	-	20.57	3.5	4.62	0.77

Source: S&P Global Market Intelligence. Standard template. Financial Sources.